• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

Sorbent Therapeutics

edit

Sorbent Therapeutics, Inc. develops treatment for end stage renal disease patients undergoing dialysis. The company develops fluid retaining polymers for therapeutic uses, such as treatment of kidney diseases. Sorbent Therapeutics, Inc. was founded in 2005 and is based in Vernon Hills, Illinois.

Recent Milestones

edit

• 
  Sorbent Therapeutics received $36M in Series B funding. (6/30/11)
  Posted 6/30/11 at 4:03am via msn.com
• 
  Sorbent Therapeutics received $21.8M in Series B funding. (9/13/10)
  Posted 9/13/10 at 6:04pm via dowjones.com
• 
  Sorbent Therapeutics added Detlef Albrecht as President & CEO.
  Posted 9/13/10 at 6:04pm
• 
  Sorbent Therapeutics added William R. Rajski as Co-founder.
  Posted 9/13/10 at 6:04pm
• 
  Sorbent Therapeutics added Howard C. Dittrich as CMO.
  Posted 4/20/12 at 6:33pm
• 
  Sorbent Therapeutics added Randall Woods as Chairman.
  Posted 4/20/12 at 6:33pm

Videos

Screenshots

edit

Sources

1. Sorbent Raises $21.8M Series B, Names New CEO (fis.dowjones.com) [edit]
2. Sorbent Therapeutics Completes $36 Million Series B Financing for Net of $53 Million (money.msn.com) [edit]